English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In patients taking antithrombotic therapy ( ATT ) , we have to manage two conflicting risks of bleeding and thromboembolism perioperatively. W e have established our ow n perioperative antithrombotic management protocol for ATT-burdened patients (“Kokura Protocol”), and b ased on th is protocol, the hospital guideline for gastroenterological and general surgery in patients re c eiving ATT was made and have been used. Thereafter, in consideration of newly launched anticoagulants called direct oral anticoagulants ( DOACs ) , the guideline has been updated with appendix on DOACs. In this paper, our current updated guideline concerning perioperative ATT management during GE and general surgery will be outline d.

journal of gastroenterology and hepatology research

Guideline for General and Gastroenterological Surgery in Patients Undergoing Antithrombotic Treatment: “Kokura Protocol 2019” with Appendix on Direct Oral Anticoagulants (DOACs)